Zenosense IncOOTC ZENO Stock Report

Zenosense, Inc. (Zenosense) is focused on commencing the business of developing specialized and non-invasive disease sensory devices. The Company's focus is on products designed to detect methicillin resistant Staphylococcus aureus (MRSA) /Staphylococcus aureus (SA) when present in healthcare environments and to detect the presence of lung cancer in a patient. The Company's product is focused on sampling the air and continuously monitoring the airborne, the volatile organic compounds (VOCs) signatures emitted, by MRSA/SA. The Company's device with a single sensor is focused on performing the entire VOC spectrum scan, as the adaptive processing software enables it to perform various scans, creating multiple virtual sensors from a single sensor. The Company's device is intended to be produced in two forms: a wearable/bed-positioned device and an adapted, fixed device positioned in the room.